MRI May Improve Prostate Cancer Monitoring

Volume tracking and longitudinal imaging may enhance assessment of progression during active surveillance.

1

MRI is crucial for monitoring prostate cancer during active surveillance, offering greater accuracy than PSA testing or biopsy.
2

Volume assessment of tumors is more clinically relevant than maximum diameter, reflecting tumor burden and growth rate.
3

The PRECISE system standardizes reporting of tumor changes but lacks quantification of change magnitude and rate.
4

A practical reporting approach emphasizes consistent volume measurement and longitudinal context for better clinical interpretation.
5

MRI's effectiveness in prostate cancer monitoring is enhanced by assessing changes over time and integrating clinical data.

1